Cutaneous Biometrics

I: Basic Concepts. 1. The Case Control Study, C. Kennedy, H.J. Heacock; J.K. Rivers. 2. Principles for the Conduct of Non-Drug Clinical Studies; G.J. Schmitt. 3. Questionnaire Design in Skin Disease Epidemiology; P. Susitaival. II: Non Invasive Evaluation of Skin Properties. 4. Scale Development for Clinical Assessment; G.J. Schmitt. 5. Evaluation of Cosmetics by Sensory Assessment; P. Busch, T. Gassenmeier. 6. Cutaneous Bioengineering; D. Iliev, et al. III: Skin Diseases and Therapy. 7. Atopic Dermatitis; A. Taïeb, J.F. Stalder. 8. A Review of the Use of Essential Fatty Acid Supplementation in Atopic Dermatitis with Emphasis on the Methodology of Trial Design; J. Berth-Jones, R. Graham-Brown. 9. Severity Scoring of Atopic Dermatitis; A.B. Sprikkelman, W.M. van Aalderen. 10. A Metric for Acneiform Eruptions of the Face; J. Wilkins. 11.Towards a New Psoriasis Severity Scoring Using Bioengineering Techniques; D.A. Schwindt, H.I. Maibach. 12. Epidemic of Melanoma: How real is it? T.-Y. Chuang. 13. Prognostic Models in Melanoma; R. Natarajan, M.A. Weinstock. 14. Photoaging; W. Cunningham. 15. Measurement in Scleroderma Clinical Trials; J. Pope. 16. Quantification of Wound Healing; L. Bolton. 17. Design of Clinical Trials to Evaluate Antimycotic Agents in the Treatment of Dermatophyte Infections; B. Abrams. 18. Sites of Contact Dermatitis in Relationship toParticular Allergens: A Follow-up Study, B. Edman. 19. Evaluating Surveillance Systems in Contact Dermatitis; A. Schnuch. 20. Sodium Lauryl Sulfate: Water Soluble Irritant Contact Dermatitis Model; C.H. Lee. 21. Quarternium-18 Bentonite in Prevention of Allergic Contact Dermatitis; R. Rietschel. 22. Personal Cleansers: Irriation and Moisturization; K. Ertel. IV: Pharmacologic Assays. 23. Small Plaque Assay; A. Lauerma. 24. The Application of the Minolta Chromameter to the Assessment of Corticosteroid-Induced Skin Blanching; R.B. Walker, et al. 25. Assaying for Bioavailability in Acne; A.H. Mills, et al. 26. In vitrol